Difference between revisions of "Team:KU Leuven/InterLabStudy/Results"
Line 580: | Line 580: | ||
</tr> | </tr> | ||
</table></div> | </table></div> | ||
+ | |||
+ | <div class ="center"> | ||
+ | <div id="image1"> | ||
+ | <img src="https://static.igem.org/mediawiki/2015/0/03/KU_Leuven_IMgraph.png" width='50%'> | ||
+ | <h4> | ||
+ | <div id=figure1>Figure 3</div> | ||
+ | Graph representing the summary of our results per device</h4> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | </div> | ||
+ | </div> | ||
<!------------------------------------------------------if you want a nice view of your photo's popping out---------------------------------------------------------> | <!------------------------------------------------------if you want a nice view of your photo's popping out---------------------------------------------------------> | ||
<div class="whiterow"></div> | <div class="whiterow"></div> |
Revision as of 18:14, 16 September 2015
Interlab Results
The results of our Interlab study are discussed in this section The minipreped samples of the given devices were validated by restriction mapping using the enzymes NcoI and XhoI. These restriction enzymes left us with bands around 267, 364, 625 and 1724 basepairs. This was validated by a gel electrophoresis (figure 1). The numbers 101, 106 and 117 stand for the devices containing the promoters J23101, J23106 and J23117 respectively.
Figure 1
Restriction digest of the three devices with NcoI and XhoI.
The restriction digest (Fig 1) shows our devices containing GFP I13504 and the promoters J23101, J23106 and J23117.The expected bands were at 267, 364, 625, 1724 bp respectively.
We made a Fluorescein standard graph and extrapolated the concentration of the GFP from the samples using the fluorescence and the absorbance values that were recorded. We went ahead with those values to calculate the mean and the standard deviation for our biological and technical replicates. We processed all the data in Microsoft excel.
Table 1: The raw fluorescence data ( excitation at 483 nm and emission at 525 nm) for LB medium containing chloramphenicol, LB medium with chloramphenicol and cells containing the biobrick J3101 and the three devices (D1, D2, D3). Biological replicates originating from three different devices are presented in the rows and the technical replicates for the devices are presented in the columns.
LB+Cam | LB+Cam+Cells | D1 | D2 | D3 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
512 | 601 | 737 | 685 | 751 | 9425 | 9322 | 9737 | 22786 | 25895 | 25048 |
546 | 594 | 754 | 641 | 641 | 9669 | 9545 | 9876 | 23159 | 26460 | 24785 |
549 | 587 | 722 | 660 | 697 | 9407 | 9321 | 9677 | 22719 | 25931 | 24935 |
Table 2: Absorbance values measured by the Tecan Safire2 plate reader at 600 nm (O.D. within 5% of 0.5 in a cuvette with a path length of 1 cm). The absorbance depends on the path length which is different in our plate reader attributing to the values lower than 0.5.
LB+Cam | LB+Cam+Cells | D1 | D2 | D3 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
0.0434 | 0.2052 | 0.2174 | 0.1942 | 0.2201 | 0.2088 | 0.2082 | 0.2154 | 0.2139 | 0.2210 | 0.2218 |
0.0405 | 0.2000 | 0.2182 | 0.1974 | 0.1980 | 0.2108 | 0.2111 | 0.2123 | 0.2143 | 0.2179 | 0.2056 |
0.0379 | 0.2064 | 0.2141 | 0.1961 | 0.2036 | 0.2137 | 0.2117 | 0.2164 | 0.2202 | 0.2261 | 0.2083 |
Table 3: Fluorescence values divided by the absorbance values for the biological and technical replicates of our three devices and for our negative control (LB medium with kanamycin and cells containing the promoter J3101), the arithmetic average and the standard deviation of the biological replicates.
D1 | D2 | D3 | |||||||
---|---|---|---|---|---|---|---|---|---|
T1 | T2 | T3 | T1 | T2 | T3 | T1 | T2 | T3 | |
B1 | 3390 | 3456 | 3372 | 45139 | 45868 | 44020 | 1065826 | 108068 | 103174 |
B2 | 3527 | 3247 | 3366 | 44774 | 45216 | 44029 | 117172 | 121432 | 114688 |
B3 | 3399 | 3237 | 3426 | 45204 | 46519 | 44718 | 112931 | 120550 | 119707 |
Brep Avg | 3439 | 3313 | 3388 | 45039 | 45868 | 44256 | 112210 | 116683 | 112523 |
BRep SD | 270 | 101 | 162 | 189 | 532 | 327 | 4376 | 6102 | 6921 |
Table 4: Fluorescence values divided by the absorbance values for the biological and technical replicates of our three devices and for our negative control (LB medium with kanamycin and cells containing the promoter J3101), the arithmetic average and the standard deviation of the technical replicates.
D1 | D2 | D3 | LB+Cam+Cells | |||||||
---|---|---|---|---|---|---|---|---|---|---|
B1 | B2 | B3 | B1 | B2 | B3 | B1 | B2 | B3 | ||
T1 | 3390 | 3527 | 3399 | 45139 | 44774 | 45204 | 106526 | 117172 | 112931 | 2929 |
T2 | 3456 | 3247 | 3237 | 45868 | 45216 | 46519 | 108068 | 121432 | 120550 | 2970 |
T3 | 3372 | 3366 | 3426 | 44020 | 44029 | 44718 | 103174 | 114688 | 119707 | 2844 |
TRep Avg | 3406 | 3380 | 3354 | 45009 | 44673 | 45480 | 105923 | 117764 | 117729 | 2914 |
TRep SD | 36 | 115 | 140 | 760 | 490 | 761 | 2043 | 2785 | 3410 | 52 |
Table 5: Fluorescein standard curve. F1, F2 and F3 represent three technical replicates of every sample. From these technical replicates, we calculated the average F and the standardised average F’. The standardised average F’ is equal to the difference of the respective sample and the average F with a concentration of 0 ng/ ml fluorescein.
Concentration (ng/mL) | F1 | F2 | F3 | average F | average F' | SD |
---|---|---|---|---|---|---|
0 | 9 | 13 | 12 | 11 | 0 | 1.699 |
10 | 1140 | 1168 | 1151 | 1153 | 1142 | 11.518 |
25 | 2543 | 2600 | 2631 | 2591 | 2580 | 36.445 |
50 | 4822 | 5097 | 5154 | 5024 | 5013 | 144.951 |
125 | 12879 | 12902 | 12931 | 12904 | 12893 | 21.276 |
250 | 25494 | 25761 | 25765 | 25673 | 25662 | 126.818 |
375 | 37474 | 37505 | 37899 | 37626 | 37615 | 193.454 |
500 | 46698 | 49051 | 48798 | 48182 | 48171 | 1054.652 |
Figure 2
Fluorescein standard curve with varying concentrations of fluorescein: 0, 10, 25, 50, 125, 250, 375 and 500 ng/ mL. The trendline and R2 is based on the standardised values. The error bars show the variation among the technical replicates.
Table 3: Fluorescence values divided by the absorbance values for the biological and technical replicates of our three devices and for our negative control (LB medium with kanamycin and cells containing the promoter J3101), the arithmetic average and the standard deviation of the biological replicates.
D1 | D2 | D3 | |||||||
---|---|---|---|---|---|---|---|---|---|
Brep Avg | 3439 | 3313 | 3388 | 45039 | 45868 | 44256 | 112210 | 116683 | 112523 |
(Brep Avg) - (LB+cam+cells avg) | 525 | 399 | 474 | 42125 | 42954 | 41342 | 109296 | 113769 | 109609 |
Concentration (ng/mL) | 1.929 | 0.639 | 1.407 | 427.88 | 436.36 | 419.88 | 1115.64 | 1161.44 | 1118.85 |
TRep Avg | 3406 | 3380 | 3354 | 45009 | 44673 | 45480 | 105923 | 117764 | 117729 |
(Trep avg) - (LB+cam+cellsavg) | 492 | 466 | 440 | 42095 | 41759 | 42566 | 103009 | 114850 | 114815 |
Concentration (ng/mL) | 1.591 | 1.325 | 1.059 | 427.56 | 424.12 | 432.39 | 1051.27 | 1172.51 | 1172.15 |
Figure 3
Graph representing the summary of our results per device
Contact
Address: Celestijnenlaan 200G room 00.08 - 3001 Heverlee
Telephone: +32(0)16 32 73 19
Email: igem@chem.kuleuven.be